Generic Product News (April 2018)

APRIL 22, 2018

CITALOPRAM
MARKETED BY:
Camber Pharmaceuticals
COMPARE TO: Celexa (Forest Laboratories, Inc)
INDICATION: Camber has launched its generic version of Celexa (citalopram) Oral Solution, indicated for the treatment of depression. Citalopram oral solution is available in a 10-mg/5-mL 240-mL bottle.
DOSAGE FORM: Oral solution
FOR MORE INFORMATION: camberpharma.com


ISOTRETINOIN CAPSULES, USP
MARKETED BY:
Amneal Pharmaceuticals
COMPARE TO: Accutane (Roche)
INDICATION: Amneal Pharmaceuticals has launched Isotretinoin capsules, USP, an AB-rated generic for Accutane in 10-, 20-, 30, and 40-mg strengths. Isotretinoin capsules are indicated for the treatment of severe recalcitrant nodular acne.
DOSAGE FORM: Capsules
FOR MORE INFORMATION: amneal.com


BUMETANIDE TABLETS, USP
MARKETED BY:
Upsher-Smith
COMPARE TO: Bumex (Hoffmann-La Roche, Inc)
INDICATION: The FDA has approved Upsher-Smith Laboratories’ abbreviated new drug application for Bumetanide tablets, the generic version of Bumex. Bumenatide tablets are indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome.
DOSAGE FORM: Tablets
FOR MORE INFORMATION: upsher-smith.com


MEMANTINE HYDROCHLORIDE
MARKETED BY:
Amneal Pharmaceuticals
COMPARE TO: Namenda XR (Allergan)
INDICATION: Amneal Pharmaceuticals has launched Memantine Hydrochloride extended-release capsules, the company’s AB-rated equivalent for Namenda XR in 7-, 14-, 21-, and 28- strengths. Namenda XR is indicated for the treatment of moderate to severe dementia of the Alzheimer type.
DOSAGE FORM: Extended-release capsules
FOR MORE INFORMATION: amneal.com

SHARE THIS
16